Next Article in Journal
Safety, Tolerability, and Immunogenicity of V160, a Conditionally Replication-Defective Cytomegalovirus Vaccine, in Healthy Japanese Men in a Randomized, Controlled Phase 1 Study
Next Article in Special Issue
Development of a Novel Anti-CD44 Variant 5 Monoclonal Antibody C44Mab-3 for Multiple Applications against Pancreatic Carcinomas
Previous Article in Journal
Intravenous Immunoglobulins as Immunomodulators in Autoimmune Diseases and Reproductive Medicine
 
 
Due to scheduled maintenance work on our database systems, there may be short service disruptions on this website between 10:00 and 11:00 CEST on June 14th.
Review

Article Versions Notes

Antibodies 2023, 12(1), 21; https://doi.org/10.3390/antib12010021
Action Date Notes Link
article xml file uploaded 3 March 2023 07:54 CET Original file -
article xml uploaded. 3 March 2023 07:54 CET Update https://www.mdpi.com/2073-4468/12/1/21/xml
article pdf uploaded. 3 March 2023 07:54 CET Version of Record https://www.mdpi.com/2073-4468/12/1/21/pdf
article html file updated 3 March 2023 07:55 CET Original file -
article html file updated 20 March 2023 20:28 CET Update https://www.mdpi.com/2073-4468/12/1/21/html
Back to TopTop